Compare Illinois Tool Works Inc. (ITW) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illinois Tool Works Inc. vs Kymera Therapeutics Inc. Common Stock — how do they compare? Illinois Tool Works Inc. trades at $271.34 (market cap $76.75B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B). The key difference: Illinois Tool Works Inc. is far larger — about 8.7× Kymera Therapeutics Inc. Common Stock's market cap, and Illinois Tool Works Inc. pays a 2.55% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illinois Tool Works Inc. for 66 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| ITW | KYMR | |
|---|---|---|
Market Cap | $76.75B | $8.87B |
Volume | 1,222,646 | 779,107 |
Sector | Industrials | Health |
52-Week High | $299.60 | $127.31 |
52-Week Low | $241.07 | $55.80 |
Typical Hold Time | 66 Days | 0 Days |
Enterprise Value | $85.60B | $8.26B |
Dividend Yield | 2.55% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ITW trades at $266.32, up 0.46% today, with a bearish technical signal but strong fundamentals including a 19.39% net income margin and consistent earnings beats. The stock is supported by a recent dividend raise to $1.72 and positive analyst upgrades, though it faces headwinds in automotive and foodservice segments. Cash flow trends show stable operations, with 2026 net cash flow projected at $51 million.
Outlook is mixed: valuation metrics like P/E of 24.12 are reasonable for a Dividend King with 59 years of increases, but high debt-to-asset ratio of 55.54% and bearish technicals pose risks. Upside to the $276.86 consensus price target depends on sustaining organic growth amid sector weaknesses.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
